Compound Profile

Nicotinamide Mononucleotide

NMN is an NAD+ precursor studied for metabolic and aging related biomarkers.

Last reviewed:

C Preliminary

Monograph visual

Nicotinamide Mononucleotide

The Hippie Scientist

Where to go next — guides & comparisons

Continue reading

Quick Stats

Evidence level

Limited evidence

Typical onset

Varies by prep

Safety rating

Use extra caution: Safety review pending

Best for

NAD+ Metabolism, Mitochondrial Pathways

Avoid / review if

Antihypertensive Medication May Have An Additive Blood Pressure Lowering Effect

Safety & Cautions

Review before use if any apply: Antihypertensive Medication May Have An Additive Blood Pressure Lowering Effect.

Evidence-based safety

Caution when combined

These pairings share a flagged risk mechanism. They are additive-effect cautions derived from contraindication data, not confirmed clinical interactions. Consult a clinician before combining.

Moderate Caution

191 flagged pairings

Blood-sugar lowering · Blood-pressure effects

Browse the grouped cautions below. The list scrolls inside this card when long.

Blood-sugar lowering
Blood-pressure effects

Evidence Summary

C Preliminary

Evidence lens

Useful signal, but study design, dose, and population still matter.

ModerateLimited evidence

Human clinical evidence: Present in source signals

Mechanistic / preclinical: Mechanism mapped — Mitochondrial Support · Metabolic Regulation · Glucose Metabolism Support

Research maturity: Preliminary or mixed — main contexts: NAD+ Metabolism · Mitochondrial Pathways

Safety boundary: Safety note available — Review before use if any apply: Antihypertensive Medication May Have An Additive Blood Pressure Lowering Effect.

Evidence Strength

Confidence estimate based on the design quality and consistency of published clinical trials.

Limited evidence

Nicotinamide Mononucleotide has a limited evidence evidence rating.

General wellnessGeneral wellness
Effects
2
How evidence grades work

Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.

A

Strong

Multiple RCTs, consistent direction, adequate effect size

B

Moderate

Some RCTs or consistent observational data in humans

C

Preliminary / Mixed

Animal or in-vitro only, or conflicting human data

D

Traditional / Theoretical

Traditional use only; no controlled human trials

How Nicotinamide Mononucleotide Works

Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.

Mechanism Pathway — How Nicotinamide Mononucleotide Works

How Nicotinamide Mononucleotide WorksNicotinamide Mononucleotide acts on pathways via mitochondrial (biogenesis), leading to nad+ metabolism.Nicotinamide MononucleotideBiological pathwayMitochondrialBiogenesisNad+ MetabolismObservable outcomeMetabolicRegulation
CompoundTarget / ReceptorMechanismEffect / Outcome
Mechanisms & Biological Pathways▼

Preclinical mechanism details from scientific profiles; these represent plausible pathways but do not guarantee clinical efficacy in humans.

Mitochondrial SupportMetabolic RegulationGlucose Metabolism Support

Condition guides

Fat lossEnergyAnxietyBlood pressureCognition

Continue exploring

Related research paths

Compare & Sourcing

Compare side-by-side tradeoffs or verify active marker guidelines.

Review available sources for Nicotinamide Mononucleotide

Independent database mapping — evaluated separately from safety and efficacy scores.

Check sourcing options

Affiliate Disclosure: Shopping links may earn this site a commission at no cost to you. Links are chosen on quality and availability, never commission tiers; safety warnings and evidence ratings stay independent.

Related alternatives

BerberineAlpha Lipoic AcidAspalathinAstragalin

Herbs for similar conditions

Aloe VeraTarragonBerberisIndian Barberry

Tradeoffs

Free safety checklist

Get the Nicotinamide Mononucleotide evidence notes

Occasional research updates, safety context, and product-quality checks for supplement decisions.

We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.

Safety first · Harm reduction

This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.

Learn how we evaluate confidence, safety, and intensity on the methodology page.

Editorial Review

Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.

Editorial Standards →
← Back to compounds librarySafety checker →

Compound profile context

How to interpret Nicotinamide Mononucleotide

Nicotinamide Mononucleotide dosage by use case, onset and duration, safety limits, and interactions for nad+ metabolism, graded against research. Limited… Use this compound profile to understand mechanism, evidence quality, and practical safety context before comparing products or building a stack. A biochemical pathway connection can be useful for discovery, but it is not the same as proven benefit in humans.

When reviewing Nicotinamide Mononucleotide, separate the active molecule from the product category around it. Dose form, absorption, extract standardization, medication interactions, and individual sensitivity can change the real-world risk-benefit picture.

For supplement planning, avoid combining multiple compounds with overlapping sedating, stimulating, serotonergic, blood-pressure, anticoagulant, or liver-metabolism effects unless a qualified clinician has reviewed the context.